Overview

Growth Response in Girls With Turner Syndrome

Status:
Completed
Trial end date:
2003-05-21
Target enrollment:
0
Participant gender:
Female
Summary
This trial is conducted in Europe. The aim of the trial is to evaluate growth response of two somatropin dose regimens in girls with Turner Syndrome.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novo Nordisk A/S
Criteria
Inclusion Criteria:

- Turner syndrome

- If age below 3 years, either body height below - 1 SD (standard deviation) with
average growth velocity according to chronological age or body height below 0 SD with
growth velocity below -1 SD according to chronological age

- If age above 3 years, body height below - 1 SD with average growth velocity according
to chronological age

- Measured parental height available

- Written informed consent